Diabetic Therapy
METSIFERâ„¢ PG1
Glimepiride 1mg + Metformin 500mg + Pioglitazone 15mg
Dosage Form
Tablets (bi-layered)
Packing
10x15 Blister
MRP
₹1425
Prescribed By
Diabetologist, Endocrinologist, General Physician, Internal Medicine, Family Medicine
Quick Facts
Form
Bi-Layered Tablets
Pack
10×15 Blister
MRP
₹1425
Prescribed By
Diabetologist, Endocrinologist, General Physician
Key Benefits
01
Pioglitazone improves insulin sensitivity — particularly useful in insulin-resistant patients.
02
Three-drug combination covers multiple blood sugar control mechanisms.
03
Lower Glimepiride dose minimises hypoglycaemia risk.
04
Convenient single bi-layered tablet.
Mechanism of Action
Glimepiride stimulates insulin secretion. Metformin reduces hepatic glucose. Pioglitazone improves insulin sensitivity in fat and muscle tissue by acting on PPAR-gamma receptors. Three distinct mechanisms for comprehensive glucose control.
Indications
Type 2 diabetes with significant insulin resistance, particularly in obese patients.
Dosage & Administration
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
Why METSIFERâ„¢ PG1?
METSIFER PG1 targets insulin resistance specifically with Pioglitazone alongside the established Glimepiride-Metformin base — ideal for patients with prominent insulin resistance.
